GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tribute Pharmaceuticals Canada Inc (OTCPK:TBUFF) » Definitions » Shiller PE Ratio

Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Shiller PE Ratio : (As of Apr. 29, 2024)


View and export this data going back to . Start your Free Trial

What is Tribute Pharmaceuticals Canada Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Tribute Pharmaceuticals Canada Shiller PE Ratio Historical Data

The historical data trend for Tribute Pharmaceuticals Canada's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tribute Pharmaceuticals Canada Shiller PE Ratio Chart

Tribute Pharmaceuticals Canada Annual Data
Trend Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tribute Pharmaceuticals Canada Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Tribute Pharmaceuticals Canada's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tribute Pharmaceuticals Canada's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tribute Pharmaceuticals Canada's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tribute Pharmaceuticals Canada's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Tribute Pharmaceuticals Canada's Shiller PE Ratio falls into.



Tribute Pharmaceuticals Canada Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Tribute Pharmaceuticals Canada's E10 for the quarter that ended in Sep. 2015 is calculated as:

For example, Tribute Pharmaceuticals Canada's adjusted earnings per share data for the three months ended in Sep. 2015 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2015 (Change)*Current CPI (Sep. 2015)
=0.008/100.4214*100.4214
=0.008

Current CPI (Sep. 2015) = 100.4214.

Tribute Pharmaceuticals Canada Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200512 -0.030 85.015 -0.035
200603 -0.020 85.805 -0.023
200606 -0.009 86.516 -0.010
200609 -0.010 86.279 -0.012
200612 0.089 86.437 0.103
200703 -0.009 87.780 -0.010
200706 0.000 88.412 0.000
200709 0.010 88.412 0.011
200712 0.000 88.491 0.000
200803 0.000 88.965 0.000
200806 0.000 91.177 0.000
200809 0.000 91.414 0.000
200812 0.008 89.518 0.009
200903 0.000 90.071 0.000
200906 0.009 90.940 0.010
200909 0.000 90.624 0.000
200912 0.000 90.703 0.000
201003 -0.010 91.335 -0.011
201006 0.019 91.809 0.021
201009 0.058 92.362 0.063
201012 -0.040 92.836 -0.043
201103 -0.010 94.338 -0.011
201106 0.000 94.654 0.000
201109 0.000 95.286 0.000
201112 -0.010 94.970 -0.011
201203 -0.020 96.155 -0.021
201206 -0.019 96.076 -0.020
201209 -0.020 96.392 -0.021
201212 -0.040 95.760 -0.042
201303 -0.059 97.103 -0.061
201306 -0.019 97.182 -0.020
201309 -0.048 97.419 -0.049
201312 0.000 96.945 0.000
201403 -0.054 98.604 -0.055
201406 -0.083 99.473 -0.084
201409 0.027 99.394 0.027
201412 -0.009 98.367 -0.009
201503 -0.040 99.789 -0.040
201506 -0.065 100.500 -0.065
201509 0.008 100.421 0.008

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Tribute Pharmaceuticals Canada  (OTCPK:TBUFF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Tribute Pharmaceuticals Canada Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Tribute Pharmaceuticals Canada's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Business Description

Traded in Other Exchanges
N/A
Address
Tribute Pharmaceuticals Canada Inc was incorporated under the Business Corporations Act (Ontario) on November 14, 1994. The Company is a specialty pharmaceutical company. It conducts acquisition, licensing, development and promotion of healthcare products in Canada. It sells Uracyst and NeoVisc internationally through a number of strategic partnerships. The Company's portfolio of assets includes nine product lines, eight of which are on the market in Canada, including: NeoVisc, NeoVisc Single Dose, Uracyst, BladderChek, Bezalip SR, Soriatane, Cambia, Daraprim, Collatamp G, and MycoVa. The Company markets its products in Canada through its own sales force and currently has licensing agreements for the distribution of select products in over 20 countries, and continues to expand this footprint. It faces product competition from companies marketing competing pharmaceutical products and medical devices in Canada. The Company's operations are or may be subject to various federal, provincial, state and local laws, regulations and recommendations relating to the marketing of products and relationships with treating physicians, data protection, safe working conditions, laboratory and manufacturing practices, the export of products to certain countries and the purchase, storage, movement, use and disposal of hazardous or potentially hazardous substances.
Executives
John M Gregory director, 10 percent owner
Sj Strategic Investments Llc 10 percent owner
Joan P Gregory other: Member 340 EDGEMONT AVE., SUITE 500, BRISTOL TN 37620
James M Gregory other: Member 340 EDGEMONT AVE., SUITE 500, BRISTOL TN 37620
Susan Gregory other: Member 340 MARTIN LUTHER KING, JR. BLVD, SUITE 200, BRISTOL TN 37620

Tribute Pharmaceuticals Canada (Tribute Pharmaceuticals Canada) Headlines

No Headlines